332 related articles for article (PubMed ID: 25493373)
1. The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.
Li Y; Go VL; Sarkar FH
Pancreas; 2015 Jan; 44(1):1-10. PubMed ID: 25493373
[TBL] [Abstract][Full Text] [Related]
2. Developments in miRNA gene signaling pathways in pancreatic cancer.
Vorvis C; Koutsioumpa M; Iliopoulos D
Future Oncol; 2016 May; 12(9):1135-50. PubMed ID: 26984178
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer.
Li Y; Sarkar FH
Int J Biol Sci; 2016; 12(3):326-37. PubMed ID: 26929739
[TBL] [Abstract][Full Text] [Related]
4. The epigenome and cancer prevention: A complex story of dietary supplementation.
Lee HS; Herceg Z
Cancer Lett; 2014 Jan; 342(2):275-84. PubMed ID: 22266189
[TBL] [Abstract][Full Text] [Related]
5. Noncoding RNAs and pancreatic cancer.
Peng JF; Zhuang YY; Huang FT; Zhang SN
World J Gastroenterol; 2016 Jan; 22(2):801-14. PubMed ID: 26811626
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic targeting in pancreatic cancer.
van Kampen JG; Marijnissen-van Zanten MA; Simmer F; van der Graaf WT; Ligtenberg MJ; Nagtegaal ID
Cancer Treat Rev; 2014 Jun; 40(5):656-64. PubMed ID: 24433955
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of key microRNAs in pancreatic cancer development.
Baradaran B; Shahbazi R; Khordadmehr M
Biomed Pharmacother; 2019 Jan; 109():1008-1015. PubMed ID: 30551350
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-gene signaling pathways in pancreatic cancer.
Drakaki A; Iliopoulos D
Biomed J; 2013; 36(5):200-8. PubMed ID: 24225187
[TBL] [Abstract][Full Text] [Related]
9. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies.
Matsuoka T; Yashiro M
World J Gastroenterol; 2016 Jan; 22(2):776-89. PubMed ID: 26811624
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs as biomarkers and perspectives in the therapy of pancreatic cancer.
Xia T; Chen XY; Zhang YN
Mol Cell Biochem; 2021 Dec; 476(12):4191-4203. PubMed ID: 34324119
[TBL] [Abstract][Full Text] [Related]
11. Negative correlation of ITCH E3 ubiquitin ligase and miRNA-106b dictates metastatic progression in pancreatic cancer.
Luo ZL; Luo HJ; Fang C; Cheng L; Huang Z; Dai R; Li K; Tian FZ; Wang T; Tang LJ
Oncotarget; 2016 Jan; 7(2):1477-85. PubMed ID: 26621835
[TBL] [Abstract][Full Text] [Related]
12. Differentially expressed miRNAs in cancer-stem-like cells: markers for tumor cell aggressiveness of pancreatic cancer.
Bao B; Ali S; Ahmad A; Li Y; Banerjee S; Kong D; Aboukameel A; Mohammad R; Van Buren E; Azmi AS; Sarkar FH
Stem Cells Dev; 2014 Aug; 23(16):1947-58. PubMed ID: 24734907
[TBL] [Abstract][Full Text] [Related]
13. Aberrant microRNAs expression patterns in pancreatic cancer and their clinical translation.
Du Y; Liu M; Gao J; Li Z
Cancer Biother Radiopharm; 2013 Jun; 28(5):361-9. PubMed ID: 23621126
[TBL] [Abstract][Full Text] [Related]
14. Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer.
Pal A; Ojha A; Ju J
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139352
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential.
Rawat M; Kadian K; Gupta Y; Kumar A; Chain PSG; Kovbasnjuk O; Kumar S; Parasher G
Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31557962
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial strategies employing nutraceuticals for cancer development.
Shukla Y; George J
Ann N Y Acad Sci; 2011 Jul; 1229():162-75. PubMed ID: 21793852
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals.
Ahmad A; Li Y; Bao B; Kong D; Sarkar FH
Mol Nutr Food Res; 2014 Jan; 58(1):79-86. PubMed ID: 24272883
[TBL] [Abstract][Full Text] [Related]
18. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer stem cells: new insight into a stubborn disease.
Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
[TBL] [Abstract][Full Text] [Related]
20. Targeting miRNAs for pancreatic cancer therapy.
Shi M; Xie D; Gaod Y; Xie K
Curr Pharm Des; 2014; 20(33):5279-86. PubMed ID: 24479803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
